PlainPharmaWatch

CMS Open Payments · Program Year 2024

ACADIA Pharmaceuticals Inc

ACADIA Pharmaceuticals Inc reported $10,214,682.73 in payments to 24,622 physicians and teaching hospitals across 25,609 transactions.

See the rankings → How this is sourced
$10.2M
Total payments
25,609
Transactions
24,622
Recipients
−$504.6K
General Payments vs PY2023

ACADIA Pharmaceuticals Inc reported $10,214,682.73 in payments to 24,622 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #171 of 1,925 reporting manufacturers (0.1% of all US industry payments), averaging $414.86 per recipient across 6 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

ACADIA Pharmaceuticals Inc pairs top-10% payment volume with an unusually diversified payment pattern across a wide recipient base.

#171
of 1,925 companies
0.1%
of all US industry payments
0.0%
paid to its single top recipient
6
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

ACADIA Pharmaceuticals Inc's CMS-reported General Payments decreased by $504.6K (−16.1%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: ACADIA PHARMACEUTICALS INCPY2023: ACADIA PHARMACEUTICALS INCPY2024: ACADIA Pharmaceuticals Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$3.1MPY2024$2.6M
PY2023
$3,141,321.51
PY2024
$2,636,726.91

How ACADIA Pharmaceuticals Inc ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

ACADIA Pharmaceuticals Inc's total vs. every reporting company

CMS Open Payments, Program Year 2024

$10,214,683 Top 9% higher than 91% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Below this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). This entry sits in this band. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for ACADIA Pharmaceuticals Inc

In Program Year 2024, ACADIA Pharmaceuticals Inc reported $10,214,682.73 in payments to 24,622 physicians and teaching hospitals across 25,609 individual transactions, an average of $398.87 per transaction and $414.86 per recipient. That total places ACADIA Pharmaceuticals Inc at rank #171 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.1% slice of all industry payments reported nationwide for the year.

"Compensation for Services Other Than Consulting" leads the 6-category general-payment breakdown below at $1.5M (15.1% of the company's reported total, 687 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

"Compensation for Services Other Than Consulting" leads ACADIA Pharmaceuticals Inc's 6-category general-payment breakdown at $1.5M, 15.1% of the reported total.

How ACADIA Pharmaceuticals Inc divides its payments

General-payment categories, ordered by reported total

1. Compensation for Services…$1.5M2. Food and Beverage$620.0K3. Consulting Fee$275.2K4. Travel and Lodging$195.0K5. Education$5.7K6. Space Rental or Facility …$2.0K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $1.5M 687
Food and Beverage $620.0K 22,139
Consulting Fee $275.2K 178
Travel and Lodging $195.0K 774
Education $5.7K 843
Space Rental or Facility Fees $2.0K 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $361,724.78 (13.7%) of $2,636,726.91 in this company's General Payments records across 7,695 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for ACADIA Pharmaceuticals Inc

The five named recipients with the highest reported General Payments from this company

Fahd Amjad$76.3KStuart Isaacson$74.0KCherian Karunapuzha$72.2KMazhar Khowaja$70.5KCaroline Buchanan$68.6K
  1. 1

    Fahd Amjad

    $76,330.75 across 135 reported transactions

  2. 2

    Stuart Isaacson

    $74,045.67 across 61 reported transactions

  3. 3

    Cherian Karunapuzha

    $72,233.61 across 112 reported transactions

  4. 4

    Mazhar Khowaja

    $70,539.80 across 89 reported transactions

  5. 5

    Caroline Buchanan

    $68,574.95 across 108 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $398.87. Average per recipient: $414.86.

Total Amount

$10,214,682.73

Avg per Transaction

$398.87

Avg per Recipient

$414.86

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

ACADIA Pharmaceuticals Inc Share

0.1%

#171 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to ACADIA Pharmaceuticals Inc

Digital Diagnostics Inc.

$10.2M 27 recipients

Medacta USA, Inc.

$10.2M 6,621 recipients

National Marrow Donor Program

$10.2M 1,391 recipients

Mallinckrodt Hospital Products Inc.

$10.3M 37,960 recipients

OsteoCentric Technologies, Inc.

$10.1M 917 recipients

Travere Therapeutics, Inc.

$10.4M 21,321 recipients

Frequently Asked Questions

How much did ACADIA Pharmaceuticals Inc pay to physicians and hospitals in 2024? ▾
0.1% of all industry payments reported to CMS Open Payments for 2024 came from ACADIA Pharmaceuticals Inc, totaling $10,214,682.73 across 25,609 transactions to physicians and hospitals.
How many physicians received payments from ACADIA Pharmaceuticals Inc? ▾
24,622 physicians and teaching hospitals received payments from ACADIA Pharmaceuticals Inc in 2024, averaging $414.86 per recipient.
What types of payments did ACADIA Pharmaceuticals Inc make? ▾
6 categories of general payment make up ACADIA Pharmaceuticals Inc's reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Compensation for Services Other Than Consulting" at $1.5M, representing 15.1% of the company's reported total.
How does ACADIA Pharmaceuticals Inc rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, ACADIA Pharmaceuticals Inc ranks #171 by total payment amount.
What is the average payment size from ACADIA Pharmaceuticals Inc? ▾
ACADIA Pharmaceuticals Inc's 25,609 transactions to 24,622 recipients in 2024 averaged $398.87 per transaction.
Where does the payment data for ACADIA Pharmaceuticals Inc come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download ACADIA Pharmaceuticals Inc's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.